Quinoa seed: A source of lipophilic nutraceuticals for the prevention of metabolic syndrome in a rat model

Metabolic syndrome (MS) is a cluster of metabolic changes including hypertriglyceridemia, elevated glucose tolerance and fatty liver. The aim of this research was to study the bioactivity of petroleum ether extracts prepared from quinoa 1 and Hualhuas quinoa in a MS rat model. Fatty acids and α-toc...

Full description

Bibliographic Details
Main Authors: S. Y. Al-Okbi, T. E. Hamed, T. A. Elewa, A .A. Ramadan, B. A. Bakry, M. F. El Karamany
Format: Article
Language:English
Published: Consejo Superior de Investigaciones Científicas 2024-03-01
Series:Grasas y Aceites
Subjects:
Online Access:https://grasasyaceites.revistas.csic.es/index.php/grasasyaceites/article/view/2156
_version_ 1827288356558471168
author S. Y. Al-Okbi
T. E. Hamed
T. A. Elewa
A .A. Ramadan
B. A. Bakry
M. F. El Karamany
author_facet S. Y. Al-Okbi
T. E. Hamed
T. A. Elewa
A .A. Ramadan
B. A. Bakry
M. F. El Karamany
author_sort S. Y. Al-Okbi
collection DOAJ
description Metabolic syndrome (MS) is a cluster of metabolic changes including hypertriglyceridemia, elevated glucose tolerance and fatty liver. The aim of this research was to study the bioactivity of petroleum ether extracts prepared from quinoa 1 and Hualhuas quinoa in a MS rat model. Fatty acids and α-tocopherol were assessed in the extracts. MS was induced by feeding a high fructose-high fat diet (HFFD). Four groups of rats were assigned: the control group, fed a balanced diet; the control group, fed a HFFD diet; and two test groups, fed on a HFFD diet and treated by either quinoa 1 or hualhuas extract. The Glucose tolerance, plasma lipids, oxidative stress biomarkers, liver lipids and histopathology of the liver and heart were assessed. The results showed that extracts from both quinoa varieties had the potential to prevent MS; although quinoa 1 was more effective. In both varieties, the major fatty acid was linoleic. Hualhuas showed a higher percentage of linolenic acid than quinoa 1; while more alpha-tocopherol was present in quinoa1.
first_indexed 2024-04-24T11:29:44Z
format Article
id doaj.art-461cf0cc39434a2c94c42eae323a204c
institution Directory Open Access Journal
issn 0017-3495
1988-4214
language English
last_indexed 2024-04-24T11:29:44Z
publishDate 2024-03-01
publisher Consejo Superior de Investigaciones Científicas
record_format Article
series Grasas y Aceites
spelling doaj.art-461cf0cc39434a2c94c42eae323a204c2024-04-10T10:29:45ZengConsejo Superior de Investigaciones CientíficasGrasas y Aceites0017-34951988-42142024-03-0175110.3989/gya.1104222Quinoa seed: A source of lipophilic nutraceuticals for the prevention of metabolic syndrome in a rat modelS. Y. Al-Okbi0T. E. Hamed1T. A. Elewa2A .A. Ramadan3B. A. Bakry4M. F. El Karamany5Nutrition and Food Sciences Department, National Research CentreNutrition and Food Sciences Department, National Research CentreField Crops Research Department, National Research CentreNutrition and Food Sciences Department, National Research CentreField Crops Research Department, National Research CentreField Crops Research Department, National Research Centre Metabolic syndrome (MS) is a cluster of metabolic changes including hypertriglyceridemia, elevated glucose tolerance and fatty liver. The aim of this research was to study the bioactivity of petroleum ether extracts prepared from quinoa 1 and Hualhuas quinoa in a MS rat model. Fatty acids and α-tocopherol were assessed in the extracts. MS was induced by feeding a high fructose-high fat diet (HFFD). Four groups of rats were assigned: the control group, fed a balanced diet; the control group, fed a HFFD diet; and two test groups, fed on a HFFD diet and treated by either quinoa 1 or hualhuas extract. The Glucose tolerance, plasma lipids, oxidative stress biomarkers, liver lipids and histopathology of the liver and heart were assessed. The results showed that extracts from both quinoa varieties had the potential to prevent MS; although quinoa 1 was more effective. In both varieties, the major fatty acid was linoleic. Hualhuas showed a higher percentage of linolenic acid than quinoa 1; while more alpha-tocopherol was present in quinoa1. https://grasasyaceites.revistas.csic.es/index.php/grasasyaceites/article/view/2156Fatty acidsFructoseLipophilic extractsMetabolic syndromeQuinoa seedTocopherol
spellingShingle S. Y. Al-Okbi
T. E. Hamed
T. A. Elewa
A .A. Ramadan
B. A. Bakry
M. F. El Karamany
Quinoa seed: A source of lipophilic nutraceuticals for the prevention of metabolic syndrome in a rat model
Grasas y Aceites
Fatty acids
Fructose
Lipophilic extracts
Metabolic syndrome
Quinoa seed
Tocopherol
title Quinoa seed: A source of lipophilic nutraceuticals for the prevention of metabolic syndrome in a rat model
title_full Quinoa seed: A source of lipophilic nutraceuticals for the prevention of metabolic syndrome in a rat model
title_fullStr Quinoa seed: A source of lipophilic nutraceuticals for the prevention of metabolic syndrome in a rat model
title_full_unstemmed Quinoa seed: A source of lipophilic nutraceuticals for the prevention of metabolic syndrome in a rat model
title_short Quinoa seed: A source of lipophilic nutraceuticals for the prevention of metabolic syndrome in a rat model
title_sort quinoa seed a source of lipophilic nutraceuticals for the prevention of metabolic syndrome in a rat model
topic Fatty acids
Fructose
Lipophilic extracts
Metabolic syndrome
Quinoa seed
Tocopherol
url https://grasasyaceites.revistas.csic.es/index.php/grasasyaceites/article/view/2156
work_keys_str_mv AT syalokbi quinoaseedasourceoflipophilicnutraceuticalsforthepreventionofmetabolicsyndromeinaratmodel
AT tehamed quinoaseedasourceoflipophilicnutraceuticalsforthepreventionofmetabolicsyndromeinaratmodel
AT taelewa quinoaseedasourceoflipophilicnutraceuticalsforthepreventionofmetabolicsyndromeinaratmodel
AT aaramadan quinoaseedasourceoflipophilicnutraceuticalsforthepreventionofmetabolicsyndromeinaratmodel
AT babakry quinoaseedasourceoflipophilicnutraceuticalsforthepreventionofmetabolicsyndromeinaratmodel
AT mfelkaramany quinoaseedasourceoflipophilicnutraceuticalsforthepreventionofmetabolicsyndromeinaratmodel